Search
Now showing items 1-10 of 16
HIV-associated tuberculosis.
(Hindawi Publishing Corporation., 2010)
The intersecting HIV and Tuberculosis epidemics in countries with a high disease burden of both infections pose many challenges and opportunities. For patients infected with HIV in high TB burden countries, the diagnosis ...
Time for gender mainstreaming in editorial policies.
(International AIDS Society., 2011)
The HIV epidemic has been continuously growing among women, and in some parts of the world, HIV-infected women outnumber men. Women’s greater vulnerability to HIV, both biologically and socially, influences their health ...
Antiretroviral prophylaxis: a defining moment in HIV control.
(Elsevier., 2011)
No abstract available.
Drug concentrations after topical and oral antiretroviral pre-exposure prophylaxis: implications for HIV prevention in women.
(Elsevier., 2011)
No abstract available.
Strengthening HIV services for pregnant women: an opportunity to reduce maternal mortality rates in Southern Africa/Sub-Saharan Africa.
(Wiley-Blackwell., 2010)
Reliable data from South Africa emanating from WHO recommendations for the Safe Motherhood programme
underscores HIV/AIDS as the most common cause of maternal deaths. The strengthening of HIV services for pregnant women ...
Interventions to modify sexual risk behaviours for preventing HIV in homeless youth.
(John Wiley & Sons, Ltd., 2011)
Background - Homeless youth are at high risk for HIV infection as a consequence of risky
sexual behavior. Interventions in homeless youth are challenging. Assessment of the effectiveness
of interventions to modify sexual ...
Contraceptive choices, pregnancy rates, and outcomes in a microbicide trial.
(Lippincott Williams & Wilkins., 2011)
OBJECTIVE: Women who become pregnant during the conduct of biomedical human immunodeficiency virus prevention trials are taken off the study product for safety reasons. High pregnancy rates can compromise statistical ...
Epidemiological impact of Tenofovir gel on the HIV epidemic in South Africa.
(Lippincott Williams & Wilkins., 2011)
Background: Tenofovir gel, an antiretroviral-based vaginal microbicide, reduced HIV acquisition by 39% in women in a recent randomized controlled clinical trial in South Africa. Methods: To inform policy, we used a dynamical ...
CAPRISA 004 tenofovir microbicide trial: no impact of tenofovir gel on the HIV transmission bottleneck.
(Oxford University Press., 2011)
Alterations of the genital mucosal barrier may influence the number of viruses transmitted from a human immunodeficiency virus–infected source host to the newly infected individual. We used heteroduplex tracking assay and ...
Genital tract inflammation during early HIV-infection predicts higher plasma viral load set point in women.
(Oxford University Press., 2011)
Background. The biggest challenge in human immunodeficiency virus type 1 (HIV-1) prevention in Africa is the high HIV-1 burden in young women. In macaques, proinflammatory cytokine production in the genital tract is necessary ...